Richard A. Paulson, President & CEO, Director at Karyopharm Therapeutics, holds 1.16M shares in Karyopharm Therapeutics (Ticker: KPTI), holds 4.66K shares in Bluebird Bio (Ticker: BLUE).

See the Hottest Stocks Based on Insider Trading >

Richard A. Paulson
Karyopharm Therapeutics (KPTI)
President & CEO, Director

Ranked #559 out of 98,624 Corporate Insiders

Profitable Transactions

11 out of 11 Profitable Transactions

Average Return

+69.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.68%

KPTI

0.32%

BLUE

A breakdown of Richard A. Paulson's holdings

See the Top Stocks by Insiders

Insider Roles

Karyopharm Therapeutics
(KPTI)

President & CEO, Director

Bluebird Bio
(BLUE)

Director

Roles that Richard A. Paulson holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Karyopharm Therapeutics
(KPTI)

Rating:Informative Sell

Date:Nov 08, 2022 - Nov 08, 2023

Return:+85.90%

The most profitable trade made by Richard A. Paulson

See the Latest Stocks Traded by Insiders

Richard A. Paulson's Trading History

KPTI

Karyopharm Therapeutics

Apr 05, 2024

President & CEO, Director

Uninformative Sell

4.60K

$1.31M

BLUE

Bluebird Bio

Apr 05, 2023

Director

Uninformative Buy

―

$4.19K

List of latest transactions for each holding click on a transaction to see Richard A. Paulson's performance on stock

See All Insider Trading from Today

Richard A. Paulson insider profile FAQ

What is the percentage of profitable transactions made by Richard A. Paulson?

The percentage of profitable transactions made by Richard A. Paulson is 100%.

What is the average return per transaction made by Richard A. Paulson?

The average return per transaction made by Richard A. Paulson is 69.10%.

What stocks does Richard A. Paulson hold?

Richard A. Paulson holds: KPTI, BLUE stocks.

What was Richard A. Paulson’s latest transaction?

Richard A. Paulson latest transaction was an Uninformative Sell of $4.60K.

What was Richard A. Paulson's most profitable transaction?

Richard A. Paulson’s most profitable transaction was an Informative Sell of KPTI stock on November 8, 2022. The return on the trade was 85.90%.

What is Richard A. Paulson's role in Karyopharm Therapeutics?

Richard A. Paulson's role in Karyopharm Therapeutics is President & CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Richard A. Paulson Insider Profile

Richard A. Paulson Karyopharm Therapeutics (KPTI)President & CEO, Director